Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Arcturus Therapeutics Holdings (ARCT) Long-Term Debt Repayments (2022 - 2023)

Historic Long-Term Debt Repayments for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Q4 2023 value amounting to $20.0 million.

  • Arcturus Therapeutics Holdings' Long-Term Debt Repayments rose 56666.67% to $20.0 million in Q4 2023 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year change of. This contributed to the annual value of $47.4 million for FY2023, which is 84728.0% up from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Long-Term Debt Repayments stood at $20.0 million for Q4 2023, which was up 56666.67% from $27.4 million recorded in Q1 2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' Long-Term Debt Repayments ranged from a high of $27.4 million in Q1 2023 and a low of $3.0 million during Q4 2022